ZURICH, SWITZERLAND and MINNEAPOLIS, MN -- (MARKET WIRE) -- October 26, 2006 -- MD Biosciences and Medisyn Technologies announced today a discovery collaboration for the development of small molecules targeting inflammatory and neurological diseases. The collaboration is based on the discovery technology platforms available at each company and will serve to develop pre-clinically validated lead compounds within joint and airway inflammations as well as Multiple Sclerosis, pain relief and Parkinson’s Disease.
